Rineterkib (compound B) is an orally active inhibitor of ERK1/2 that exerts an antiproliferative effect by activating mutations in the MAPK pathway. This activity is particularly associated with KRAS-mutant non-small cell lung cancer, BRAF-mutant non-sma
Molecular Weight:
578.42
Purity:
>99%
CAS Number:
[1715025-32-3]
Formula:
C26H27BrF3N5O2
Target:
ERK
* VAT and and shipping costs not included. Errors and price changes excepted
